By Michael Dabaie

Qiagen N.V. U.S. shares were up 14%, to $41.24, in early trading.

Thermo Fisher Scientific Inc. said it would acquire Qiagen, a provider of molecular diagnostics and sample preparation technologies, for EUR39 ($43.38). Thermo Fisher shares were up 4%, to $316.35.

The transaction values Netherlands-based Qiagen at about $11.5 billion at current exchange rates, which includes the assumption of about $1.4 billion of net debt, Thermo Fisher said.

Qiagen generated 2019 revenue of $1.53 billion, Thermo Fisher said.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

March 03, 2020 10:12 ET (15:12 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Qiagen NV (TG:QIA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Qiagen NV Charts.
Qiagen NV (TG:QIA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Qiagen NV Charts.